Czogalla, B., Kuhn, C., Heublein, S., Schmöckel, E., Mayr, D., Kolben, T., . . . Hester, A. (2019). EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer. Journal of cancer research and clinical oncology, 145(10), . https://doi.org/10.1007/s00432-019-03017-8
Chicago Style (17th ed.) CitationCzogalla, Bastian, et al. "EP3 Receptor Is a Prognostic Factor in TA-MUC1-negative Ovarian Cancer." Journal of Cancer Research and Clinical Oncology 145, no. 10 (2019). https://doi.org/10.1007/s00432-019-03017-8.
MLA (9th ed.) CitationCzogalla, Bastian, et al. "EP3 Receptor Is a Prognostic Factor in TA-MUC1-negative Ovarian Cancer." Journal of Cancer Research and Clinical Oncology, vol. 145, no. 10, 2019, https://doi.org/10.1007/s00432-019-03017-8.
Warning: These citations may not always be 100% accurate.